Diego F. Coutinho
Rio De Janeiro, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression.
Journal: Molecular cancer therapeutics
Published: April 18, 2025
Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors.
Journal: Med (New York, N.Y.)
Published: March 23, 2022
TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes.
Journal: Blood advances
Published: June 01, 2021
Translational Strategies for Repotrectinib in Neuroblastoma.
Journal: Molecular cancer therapeutics
Published: February 09, 2021
Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor.
Journal: Pediatric blood & cancer
Published: January 21, 2021
Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor.
Journal: Molecular cancer research : MCR
Published: August 19, 2020
Myeloid malignancies-related somatic mutations in aging individuals.
Journal: Molecular genetics & genomic medicine
Published: January 21, 2019
Presence of CD34+ in Megakaryocytes in Association With p53 Expression Predicts Unfavorable Prognosis in Low-risk Myelodysplastic Syndrome Patients.
Journal: In vivo (Athens, Greece)
Published: November 05, 2018
Genetic Alterations in Essential Thrombocythemia Progression to Acute Myeloid Leukemia: A Case Series and Review of the Literature.
Journal: Frontiers in oncology
Published: September 27, 2017
Bone marrow fibrosis at diagnosis is associated with TP53 overexpression and adverse prognosis in low-risk myelodysplastic syndrome.
Journal: British journal of haematology
Published: March 21, 2017
Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes.
Journal: Revista da Associacao Medica Brasileira (1992)
Published: December 17, 2016
Last Updated: 09/26/2026